Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinxiang Aurora Biotech is a specialized biotechnology company based in China that focuses on the research, development, and large-scale production of high-quality nucleosides, nucleotides, and phosphoramidites. The company serves as a key supplier to the global pharmaceutical and diagnostic industries, providing essential building blocks for DNA and RNA synthesis, as well as modified nucleoside analogs for antiviral and anticancer research. Their product portfolio includes a wide range of carbohydrate derivatives and specialty chemicals used in drug discovery and molecular biology. With a strong emphasis on chemical synthesis and process optimization, Xinxiang Aurora Biotech supports both academic research and industrial-scale manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinxiang Aurora Biotech.